Perhaps the effective priming of the immune system preoperatively and continued suppression of PD-L1 mediated immune inhibition as well as the elimination of micro-metastatic disease could lead to improved OS with the perioperative approach compared to neoadjuvant or adjuvant only approaches [17]. Here, CD274 is linked to metastatic neoplasm.